...
首页> 外文期刊>International Journal of Clinical and Experimental Pathology >Progressive and painful wound as a feature of subcutaneous panniculitis-like T-cell lymphoma (SPTCL): report of a case and review of literature
【24h】

Progressive and painful wound as a feature of subcutaneous panniculitis-like T-cell lymphoma (SPTCL): report of a case and review of literature

机译:进行性和疼痛性伤口为皮下脂膜炎样T细胞淋巴瘤(SPTCL)的特征:一例病例报道并文献复习

获取原文
           

摘要

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is an uncommon extranodal non-Hodgkin lymphoma, with an aggressive course with no well-defined treatment. This article describes a 56-year-old man, treated surgically 7 months earlier for a subcutaneous nodosity near the left axilla, presenting with a progressive inflamed wound, pain, and high fever (39°C). Treatment with systemic antibiotics and topical anti-inflammatory dressings failed. After 7 months, the patient was diagnosed with SPTCL based on biopsy results and a multidisciplinary consultation. While undergoing systemic chemotherapy with corticosteroid therapy, his wound become more painful, larger, and covered with necrotic tissue. Fifty days after chemotherapy with corticosteroid therapy, his wound became seriously painful and increasingly necrotic. He developed a serious stomachache and abdominal distension, rapidly became comatose, and died. The aim of this case report is to present our experience of the different clinical signs of SPTCL to expedite its early diagnosis in future. We summarize the main clinical characteristics of SPTCL as a rapidly progressing and increasingly painful wound with necrotic tissue, involving a multisystem disorder, which is easily misdiagnosed, responds poorly to corticosteroid and chemotherapy treatments, and has a high mortality rate. The pathological characteristics are early inflammation, advancing to profuse infiltration of the subcutaneous adipose tissues by CD3+ and/or CD8+ T-cell lymphoma cells. Clinicians must cooperate with pathologists and oncologists to diagnose this disease as soon as possible and to avoid a misdiagnosis. The use of antibiotic and painkillers should minimize the patient’s discomfort and control rapid wound development. Future studies are required to investigate the optimal wound treatment and whether the necrotic tissue should be removed.
机译:皮下脂膜炎样T细胞淋巴瘤(SPTCL)是一种罕见的结外性非霍奇金淋巴瘤,其侵袭性病程未明确治疗。本文介绍了一位56岁的男性,他在7个月前接受了手术,因左腋窝附近出现皮下结节,出现了渐进性发炎的伤口,疼痛和高烧(39°C)。用全身抗生素和局部消炎敷料治疗失败。 7个月后,根据活检结果和多学科咨询诊断为SPTCL。在接受皮质类固醇疗法的全身化学疗法时,他的伤口变得更加疼痛,更大,并被坏死组织覆盖。接受皮质类固醇激素疗法的化疗后第五十天,他的伤口变得非常疼痛,越来越坏死。他出现了严重的胃痛和腹胀,迅速昏迷并死亡。本病例报告的目的是介绍我们对SPTCL不同临床体征的经验,以加快将来的早期诊断。我们总结了SPTCL的主要临床特征,它是一种进展迅速,越来越多的坏死性伤口,伴有坏死组织,涉及多系统疾病,很容易被误诊,对皮质类固醇和化疗的治疗反应差,死亡率高。病理特征是早期炎症,逐渐发展为CD3 +和/或CD8 + T细胞淋巴瘤细胞浸润皮下脂肪组织。临床医生必须与病理学家和肿瘤学家合作,以尽快诊断出这种疾病并避免误诊。抗生素和止痛药的使用应最大程度地减少患者的不适并控制伤口的快速发展。需要进一步的研究来研究最佳的伤口治疗方法以及是否应切除坏死组织。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号